We found that NRP1 was also detectable in HTPC-adeno and CRPC-Adeno specimens (data not shown) and primary luminal tumour samples [25], indicating that low NRP1 expression precedes transition to drug resistance. This evidence concerns the gene NRP1 and neoplasm.